Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation
- 5 July 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 126 (3) , 372-376
- https://doi.org/10.1111/j.1365-2141.2004.05053.x
Abstract
Summary: Serum procalcitonin (PCT) levels have been proposed as a new discriminative marker for bacterial and fungal infections. We analysed the diagnostic relevance of PCT in febrile episodes of neutropenic adult patients after haematopoietic stem cell transplantation (HSCT). PCT was determined prospectively in 92 febrile episodes, classified according to the final diagnosis as: neutropenic fever of unknown origin (n = 51), microbiological (n = 26) or clinical (n = 5) documented infection and non‐infectious febrile episodes (n = 10). On first day of fever, mean (±SD) PCT level was 0·3 ng/ml (0·2) in neutropenic fever of unknown origin, 0·5 ng/ml (0·7) in microbiologically confirmed infections, 0·2 ng/ml (0·2) in clinically documented infections and 1·7 (4·2) in non‐infectious fever (P = not significant). Five days after the antibiotic therapy was started, fever persisted in 29 neutropenic episodes (32%). Cases that were eventually diagnosed with invasive aspergillosis had PCT values significantly higher [10·1 ng/ml (6·7)] than all remaining groups (P = 0·027; Kruskal–Wallis). Our analysis indicates that the PCT level on first day of fever did not facilitate the differential diagnosis of neutropenic febrile episode. However, when fever persisted for more than 5 d, PCT values ≥3 ng/ml had a high sensitivity and specificity for the diagnosis of invasive aspergillosis.Keywords
This publication has 15 references indexed in Scilit:
- Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantationBone Marrow Transplantation, 2004
- Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsisBone Marrow Transplantation, 2003
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile NeutropeniaClinical Infectious Diseases, 2001
- Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlledBMJ, 2001
- Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIBritish Journal of Haematology, 2000
- Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C‐reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIBritish Journal of Haematology, 2000
- Procalcitonin — A new indicator of the systemic response to severe infectionsInfection, 1997
- Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrationsCritical Care Medicine, 1997
- High serum procalcitonin concentrations in patients with sepsis and infectionPublished by Elsevier ,1993